Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study.
SARS-CoV-2 incidence
Surveillance
cross-sectional study
homeless shelter
infection risk factors
molecular testing
Journal
Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737
Informations de publication
Date de publication:
10 07 2023
10 07 2023
Historique:
medline:
8
8
2023
pubmed:
10
7
2023
entrez:
10
7
2023
Statut:
epublish
Résumé
Homeless shelter residents and staff may be at higher risk of SARS-CoV-2 infection. However, SARS-CoV-2 infection estimates in this population have been reliant on cross-sectional or outbreak investigation data. We conducted routine surveillance and outbreak testing in 23 homeless shelters in King County, Washington, to estimate the occurrence of laboratory-confirmed SARS-CoV-2 infection and risk factors during 1 January 2020-31 May 2021. Symptom surveys and nasal swabs were collected for SARS-CoV-2 testing by RT-PCR for residents aged ≥3 months and staff. We collected 12,915 specimens from 2,930 unique participants. We identified 4.74 (95% CI 4.00-5.58) SARS-CoV-2 infections per 100 individuals (residents: 4.96, 95% CI 4.12-5.91; staff: 3.86, 95% CI 2.43-5.79). Most infections were asymptomatic at the time of detection (74%) and detected during routine surveillance (73%). Outbreak testing yielded higher test positivity than routine surveillance (2.7% versus 0.9%). Among those infected, residents were less likely to report symptoms than staff. Participants who were vaccinated against seasonal influenza and were current smokers had lower odds of having an infection detected. Active surveillance that includes SARS-CoV-2 testing of all persons is essential in ascertaining the true burden of SARS-CoV-2 infections among residents and staff of congregate settings.
Identifiants
pubmed: 37424310
doi: 10.1017/S0950268823001036
pii: S0950268823001036
pmc: PMC10540173
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e129Subventions
Organisme : CDC HHS
ID : 75D30120C09322
Pays : United States
Références
Am J Infect Control. 2021 Jun;49(6):694-700
pubmed: 33631305
N Engl J Med. 2020 Jul 9;383(2):185-187
pubmed: 32356944
Influenza Other Respir Viruses. 2023 Jan;17(1):e13092
pubmed: 36610058
Lancet Public Health. 2020 Apr;5(4):e186-e187
pubmed: 32171054
Workplace Health Saf. 2022 May;70(5):235-241
pubmed: 35112601
BMC Public Health. 2022 Jul 12;22(1):1327
pubmed: 35820879
Sci Rep. 2021 May 26;11(1):11025
pubmed: 34040014
Emerg Infect Dis. 2022 Jan;28(1):76-84
pubmed: 34856112
J Infect Dis. 2022 Aug 24;226(2):217-224
pubmed: 35091746
Vaccines (Basel). 2020 Oct 15;8(4):
pubmed: 33076405
Lancet. 2023 Mar 11;401(10379):833-842
pubmed: 36930674
CMAJ. 2020 Jun 29;192(26):E716-E719
pubmed: 32601252
Clin Infect Dis. 2021 Jul 15;73(2):324-327
pubmed: 32744615
JAMA. 2020 Jun 2;323(21):2191-2192
pubmed: 32338732
NPJ Prim Care Respir Med. 2021 Feb 26;31(1):10
pubmed: 33637750
Asian J Psychiatr. 2022 Mar;69:102987
pubmed: 34979474
J Public Health Manag Pract. 2021 May-Jun 01;27(3):285-294
pubmed: 33762544
BMC Med. 2021 May 7;19(1):116
pubmed: 33962621
Immunity. 2021 Oct 12;54(10):2172-2176
pubmed: 34626549
JAMA Netw Open. 2021 Dec 1;4(12):e2138464
pubmed: 34902035
MMWR Morb Mortal Wkly Rep. 2020 Jul 10;69(27):864-869
pubmed: 32644981
Lancet Public Health. 2021 Apr;6(4):e202-e209
pubmed: 33556328
Expert Rev Vaccines. 2020 Oct;19(10):919-936
pubmed: 32940090
Int J Infect Dis. 2021 Feb;103:243-245
pubmed: 33321208
Int J Popul Data Sci. 2021 Dec 02;5(4):1695
pubmed: 35097224
J Clin Med Res. 2021 Dec;13(12):549-555
pubmed: 35059073
Ann Intern Med. 2021 Jan;174(1):42-49
pubmed: 32931328
West J Emerg Med. 2020 Aug 17;21(5):1048-1053
pubmed: 32970553
Trials. 2020 Nov 23;21(1):956
pubmed: 33228787
Sci Total Environ. 2023 Sep 15;891:164402
pubmed: 37244609
EClinicalMedicine. 2021 Aug;38:101032
pubmed: 34316550
Lancet. 2014 Oct 25;384(9953):1529-40
pubmed: 25390578
Vaccines (Basel). 2020 Sep 16;8(3):
pubmed: 32947988